Self-optimization is the next evolutionary step for bioprocessing purification systems and, although that step is near, it ...

The biopharma industry is emerging from one of the sharpest boom-and-bust cycles in its history. Following a sharp decline in biotech venture funding (2025 deal counts down by two-thirds since 2021, ...

Vivodyne started as an idea between co-founders Andrei Georgescu (left), now Vivodyne’s CEO, and Dan Huh, PhD, professor at UPenn (right), now Vivodyne’s CSO, while Andrei performed his PhD graduate ...

MADM organoid. Fluorescent image of a mouse cortical organoid. Cells with MADM labeling (green, red, yellow) are clearly visible; the blue is DAPI nuclear staining. The MADM-labeled cells are mostly ...

A scalable platform to discover molecular glue degraders has been developed, identifying the first metabolically activated ...

In GEN’s flagship virtual event, The State of Biotech, we hear from a distinguished group of business executives, award-winning scientists, and journalists.

With the organoid working to simulate a heart with valves, the researchers had a model they could use to study four types of valve disorders.

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished goods manufacturing from late development ...

Zebrafish were bred to lack a working copy of a gene that could be studied to better understand how genetic faults could lead ...

COVID-19 can reactivate dormant viruses, including Epstein-Barr and cytomegalovirus, according to a large NIH-funded study.

The puppies represent a key first step towards addressing canine allergenicity and mark potentially a significant advance in ...

The team’s approach, which combines synthetic biology expertise, artificial intelligence, and statistical mapping techniques, enables rapid, precise reprogramming of bacteria as biotechnology tools, ...